NCT04890509 - A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions

COVID-19

Interventions

DRUG

Bemcentinib

Bemcentinib capsules will be administered orally.

OTHER

SoC

The SoC will be administered based on local guidelines.

Trial Locations (12)

Maulana Azad Medical College, New Delhi

Unity Trauma Center and ICU, Unity Hospital, Surat

Sahyadri Specialty Hospital, Pune

Chopda Medicare & Research Centre Pvt. Ltd (CMARC) - Magnum Heart Institute, Nashik

Krishna Institute of Medical Sciences (KIMS Hospitals), Secunderabad

Kasturba Medical College, Mangalore

JSS Hospital, Mysuru

Lakeview Hospital, Mowbray

Tiervlei Trial Centre, Bellville

Vergelegen Mediclinic, Somerset West

Into Research, Groenkloof

Clinical Projects Research, Worcester